```html

Zika‑Related Conjunctivitis

What is Zika‑Related Conjunctivitis?

Conjunctivitis, commonly called “pink eye,” is inflammation of the thin, transparent membrane (the conjunctiva) that lines the inside of the eyelids and covers the white part of the eye. When a person is infected with the Zika virus, the virus can involve the conjunctiva, leading to redness, tearing, and a gritty sensation. This manifestation is usually mild, self‑limited, and occurs during the acute phase of Zika infection, often together with fever, rash, and joint pain.

Although Zika‑related conjunctivitis is not a disease on its own, recognizing it is important because it can be an early clue that a person has a Zika infection—especially in travelers returning from endemic areas or in pregnant women, where Zika poses serious fetal risks.

Common Causes

Conjunctivitis can be triggered by many different agents. Below are 8–10 of the most common conditions that can produce a Zika‑related or similar presentation:

• Zika virus infection – the primary cause when conjunctivitis appears in the context of a recent mosquito bite or travel to a Zika‑endemic region.
• Dengue virus infection – another flavivirus transmitted by Aedes mosquitoes that can cause a similar red‑eye picture.
• Chikungunya virus infection – often co‑circulates with Zika; ocular inflammation may accompany severe joint pain.
• Other viral conjunctivitis – adenovirus, enterovirus, or herpes simplex virus.
• Bacterial conjunctivitis – Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, etc.
• Allergic conjunctivitis – pollen, pet dander, or environmental irritants.
• Chemical or irritant exposure – smoke, chlorine, or industrial fumes.
• Autoimmune conditions – Sjögren syndrome or Behçet disease can cause chronic red eyes.
• Contact lens misuse – poor hygiene or overwearing lenses.
• Dry‑eye syndrome – especially in older adults or those on certain medications.

Associated Symptoms

When the conjunctivitis is part of a Zika infection, patients often report a constellation of systemic signs that help differentiate it from isolated “pink eye.” Common accompanying symptoms include:

• Fever (usually low‑grade, < 38.5 °C/101.3 °F)
• Maculopapular rash that starts on the face and spreads to the trunk
• Arthralgia (painful joints), especially of the hands and feet
• Myalgia (muscle aches)
• Headache, sometimes with photophobia
• Mild fatigue or malaise
• Occasional mild gastrointestinal upset (nausea, diarrhea)
• In pregnant women: possible fetal abnormalities detected on ultrasound weeks after infection

The ocular findings themselves are usually limited to:

• Diffuse redness of the sclera and conjunctiva
• Watery or mucoid discharge (rarely purulent)
• A sensation of foreign body or burning
• Occasional mild eyelid swelling (blepharitis)

When to See a Doctor

Most cases of Zika‑related conjunctivitis improve without prescription medication, but prompt medical evaluation is essential in the following situations:

• New onset of red eye in a person who has traveled to or lives in a Zika‑endemic area within the past 14 days.
• Pregnant women (or women planning a pregnancy) with any eye redness, fever, or rash – fetal infection can have severe consequences.
• Severe eye pain, vision changes, or light sensitivity (photophobia) that persist beyond 24–48 hours.
• Purulent (yellow/green) discharge, indicating possible bacterial super‑infection.
• Swelling that involves the whole eye (orbital cellulitis) or eyelids that restricts eye opening.
• History of immune compromise (e.g., HIV, transplant, chemotherapy) where viral infections may behave more aggressively.

Diagnosis

Diagnosing Zika‑related conjunctivitis involves both clinical assessment and targeted laboratory testing.

Clinical Evaluation

• History taking – travel itinerary, mosquito exposure, onset of systemic symptoms, pregnancy status, and use of contact lenses.
• Physical examination – visual acuity testing, slit‑lamp inspection of the cornea and conjunctiva, assessment for corneal ulceration or intra‑ocular inflammation.

Laboratory Tests

• Reverse transcription polymerase chain reaction (RT‑PCR) – detects Zika viral RNA in serum, urine, or saliva within 7 days of symptom onset (CDC, 2023).
• Zika IgM serology – useful after the first week; IgM persists for several weeks to months.
• Differential testing – Dengue and Chikungunya serologies, adenovirus PCR, or bacterial cultures if purulent discharge is present.
• Pregnancy testing – mandatory for women of reproductive age with potential exposure.

Imaging (Rarely Needed)

If there is concern for posterior segment involvement (e.g., uveitis, retinal lesions), an ophthalmologist may order optical coherence tomography (OCT) or fundus photography. These findings are uncommon in uncomplicated Zika conjunctivitis.

Treatment Options

The primary goal is symptom relief while the immune system clears the virus. Below are evidence‑based medical and home‑care strategies.

Medical Treatments

• Topical lubricating eye drops (preservative‑free artificial tears) – relieve dryness and gritty sensation.
• Cold compresses – applied intermittently to reduce swelling.
• Topical antihistamine/mast‑cell stabilizer drops – if allergic component is suspected.
• Oral analgesics/antipyretics – acetaminophen or ibuprofen for fever, headache, or joint pain (avoid aspirin in children).
• Antibiotic eye drops or ointments – only when bacterial superinfection is evident (e.g., purulent discharge, worsening redness). Typical choices: erythromycin ophthalmic ointment or trimethoprim‑polymyxin B drops.
• Corticosteroid eye drops – rarely needed; only prescribed by ophthalmology for severe inflammatory response and after ruling out infection.

Home Care & Supportive Measures

• Maintain strict hand hygiene; wash hands before touching the eyes.
• Avoid wearing contact lenses until the eye is completely clear.
• Use a humidifier in dry environments to keep the ocular surface moist.
• Do not share towels, pillowcases, or cosmetics.
• Rest and stay well‑hydrated to support the immune response.

Special Considerations for Pregnancy

Pregnant women should be monitored closely by obstetrics and infectious‑disease specialists. In addition to eye care, serial ultrasounds are recommended to assess fetal development, particularly for microcephaly or other neurologic anomalies linked to congenital Zika syndrome (WHO, 2022).

Prevention Tips

Because Zika is transmitted primarily by Aedes mosquitoes, preventing bites is the most effective strategy.

• Use EPA‑registered insect repellents containing DEET, picaridin, IR3535, or oil of lemon eucalyptus (apply every 2–3 hours).
• Wear protective clothing – long sleeves, pants, and shoes when outdoors during peak biting times (early morning & late afternoon).
• Eliminate standing water around homes (flower pots, buckets, tires) to reduce mosquito breeding sites.
• Install screens on windows and doors; keep doors closed.
• Travel precautions – check CDC travel advisories before visiting endemic regions; consider postponing non‑essential travel for pregnant women.
• Safe sex practices – Zika can be sexually transmitted; use condoms or abstain for at least 8 weeks (women) or 6 months (men) after possible exposure.
• Vaccination – currently no licensed Zika vaccine; participation in clinical trials may be an option for high‑risk individuals.

Emergency Warning Signs

Key Take‑aways

Zika‑related conjunctivitis is typically a mild, self‑limited eye inflammation that appears alongside classic Zika virus symptoms. Recognizing the association is crucial for timely diagnosis, especially in pregnant women where fetal risk is high. Management focuses on supportive eye care, monitoring for secondary bacterial infection, and preventing mosquito bites to avoid further transmission. When warning signs such as intense pain, vision loss, or systemic deterioration arise, urgent evaluation is essential.

---

References:

• Centers for Disease Control and Prevention (CDC). Zika Virus: Clinical Guidance. Updated 2023.
• Mayo Clinic. Conjunctivitis (Pink Eye). Accessed May 2026.
• World Health Organization (WHO). Zika virus fact sheet. 2022.
• Cleveland Clinic. Zika Virus. 2023.
• National Institutes of Health (NIH) – National Institute of Allergy and Infectious Diseases. Zika Virus. 2024.
• American Academy of Ophthalmology. Viral Conjunctivitis. 2023.

```